Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 3

Rasagiline – a novel MAO B inhibitor in Parkinson’s disease therapy

Total article views   Abstract views HTML views PDF downloads Totals
4,564 Dovepress* 4,564 0+ 1,323 4,564
Totals 4,564 0 1,323 4,564
*Since 15 July 2007
+Since July 2016

View citations on Google Scholar